Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
7.89
-0.24 (-2.95%)
At close: Oct 1, 2026, 4:00 PM EDT
7.90
+0.01 (0.13%)
After-hours: Oct 1, 2026, 7:30 PM EDT
Exagen Market Cap
Exagen has a market cap or net worth of $191.14 million as of October 1, 2026. Its market cap has decreased by -20.96% in one year.
Market Cap
191.14M
Enterprise Value
194.21M
1-Year Change
-20.96%
Ranking
Category
Stock Price
$7.89
ChartMarket Cap Chart
Since September 19, 2019, Exagen's market cap has increased from $63.11M to $191.14M, an increase of 202.89%. That is a compound annual growth rate of 17.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 191.14M | 38.72% |
| Dec 31, 2025 | 137.79M | 90.55% |
| Dec 31, 2024 | 72.31M | 113.18% |
| Dec 29, 2023 | 33.92M | -13.39% |
| Dec 30, 2022 | 39.17M | -79.17% |
| Dec 31, 2021 | 187.99M | 12.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Freenome | 1.74B |
| OPKO Health | 1.22B |
| Castle Biosciences | 1.10B |
| Fulgent Genetics | 615.24M |
| Myriad Genetics | 405.55M |
| Biodesix | 320.97M |
| Burning Rock Biotech | 185.93M |
| Quantum Cyber | 114.33M |